Drug Approval | July 24, 2024
USFDA successfully inspects Carbogen Amcis’s manufacturing sites in Neuland and Aarau
The inspections concluded with no Form 483 observations or significant critical findings
The inspections concluded with no Form 483 observations or significant critical findings
Berlinger brings a suite of proprietary and high-quality hardware and software solutions that broaden Sensitech's end-to-end cold chain monitoring product portfolio
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
A five-day inspection was concluded successfully with no critical and no major observations raised
The inspection was concluded with few procedural observations
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Subscribe To Our Newsletter & Stay Updated
